NCT04483934 is a Phase 1, PHASE2 clinical trial of Dermal fibroblasts in Trophic Ulcer, sponsored by Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus.

What drugs are being tested in NCT04483934?

Interventions in NCT04483934: Dermal fibroblasts, LED phototherapy.

What condition does NCT04483934 study?

NCT04483934 studies Trophic Ulcer, Non-healing Wound, Non-Healing Ulcer of Skin.

Is NCT04483934 still recruiting?

NCT04483934 is currently completed. Last updated 23 July 2020.

Last reviewed 2020-07-23 · How we verify

NCT04483934

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment of Patients With Non-healing Wounds and Trophic Ulcers Using Autologous Dermal Fibroblasts

Completed Phase 1, PHASE2 Last updated 23 July 2020

What this trial tests

Phase 1, PHASE2 trial testing Dermal fibroblasts in Trophic Ulcer in 12 participants. Completed in 30 September 2016.

Timeline

28 October 2014

Primary endpoint
30 September 2016

30 September 2016

Quick facts

Lead sponsor	Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Phase	Phase 1, PHASE2
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	12
Start date	28 October 2014
Primary completion	30 September 2016
Estimated completion	30 September 2016
Sites	1 location across Belarus

Drugs / interventions tested

Dermal fibroblasts — full drug profile →
LED phototherapy

Conditions studied

Trophic Ulcer — all drugs for Trophic Ulcer →
Non-healing Wound — all drugs for Non-healing Wound →
Non-Healing Ulcer of Skin — all drugs for Non-Healing Ulcer of Skin →

Sponsor

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

Who can join

18 and older, any sex, with Trophic Ulcer or Non-healing Wound. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Treatment of patients with non-healing wounds and trophic ulcers using local LED phototherapy with local transplantation of autologous dermal fibroblasts

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus trials

Trials by the same sponsor.

NCT06167564 — Allergy Diagnostic Test Based on Microchip Technology · NA · unknown
NCT05654766 — Assesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies · unknown
NCT05520125 — Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles · Phase 1, PHASE2 · unknown
NCT05520112 — Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells · Phase 1, PHASE2 · unknown
NCT05214014 — Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells · Phase 1, PHASE2 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04483934 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Last refreshed: 23 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04483934.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing